Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent years have seen a rapid increase in the use of gut microbiota-targeting interventions, such as probiotics, for the treatment of psychiatric disorders. The objective of this update review was to evaluate all randomised controlled clinical trial evidence on the efficacy of probiotics for clinical depression. Cochrane guidelines for updated reviews were followed. By searching PubMed and Web of Science databases, we identified 546 new records since our previous review. A total of seven studies met selection criteria, capturing 404 people with depression. A random effects meta-analysis using treatment type (stand-alone vs. adjunctive) as subgroup was performed. The results demonstrated that probiotics are effective in reducing depressive symptoms when administered in addition to antidepressants (SMD = 0.83, 95%CI 0.49–1.17), however, they do not seem to offer significant benefits when used as stand-alone treatment (SMD = −0.02, 95%CI −0.34–0.30). Potential mechanisms of action may be via increases in brain-derived neurotrophic factor (BDNF) and decreases in C-reactive protein (CRP), although limited evidence is available at present. This review offers stronger evidence to support the clinical use of probiotics in depressed populations and provides an insight into the mode of administration more likely to yield antidepressant effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) study flow diagram for updated reviews. Adapted from Stovold et al. [25].](https://figures.cochat.ai/paper-figures/270ca885976b49c79212cf3fee4c2f7c/updated-review-and-meta-analysis-of-probiotics-for-the-treatment-of-clinical-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Probiotics have been recently tested to re-establish a healthy microbial status, due to their ability to balance the dysbiosis created under the depressive state [117].”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 1×
“Due to the low number of studies, and in accordance with published recommendations [24], we did not perform additional sensitivity analyses, meta-regression, or assessment of publication bias.”
ResultMind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572 · cited 2×
“Multiple animal and healthy volunteer studies have demonstrated that probiotics and the gut microbiota can alter circulating levels of pro-inflammatory and anti-inflammatory cytokines [13].”
BackgroundOtte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023 · cited 1×
“For example, a recent study in rats found that the NMDA receptor antagonist ketamine amplifies levels of the genus Lactobacilli [44], which has been found to be reduced in depressed animals, with some evidence of decreases in clinical populations as well [45,46].”
BackgroundThe neuroactive potential of the human gut microbiota in quality of life and depression
Valles-Colomer, M., Falony, G., Darzi, Y., Tigchelaar, E. F., Wang, J., Tito, R. Y., Schiweck, C., Kurilshikov, A., Joossens, M., Wijmenga, C., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0337-x · Cited by 1,963
Research works printed but not linked: 1
- Cumpston M. Changler J. Chapter IV: Updating a review Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 updated September 2020 Cochrane London, UK Available online: https://training.cochrane.org/handbook/current/chapter-iv (accessed on 17 December 2020)
Cited by
Items 101–124 of 124
Terra, S. B., Gomes, C. V., Pereira, C. R. A., Figueira, J. F., & Carvalho, V. C. P. (2025) · doi:10.48209/978-65-5417-422-2
de OLIVEIRA, W. D., & GABRIELLI, M. (2025) · doi:10.48209/978-65-5417-422-5
Doddamane, S. T., Paliwal, A., Bagul, K. R., & Patel, N. (2025) · Indian Journal of Private Psychiatry · doi:10.5005/jp-journals-10067-0178
“16 These findings collectively emphasize the potential synergistic effects of combining probiotics with traditional antidepressant therapies and highlight the nuanced role of probiotics in augmenting mental health outcomes in individuals with MDD.”
The role of nutraceuticals of natural origin in the treatment of depressive disorders
Sęk, M., Galasińska, I., Hajduk-Maślak, K., Michalik, B., Skóra, A., & Zając, D. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.82.60309
“It is noteworthy that probiotics did not demonstrate efficacy as monotherapy, however only a limited number of trials regarding their efficacy were included in the analysis [33].”
Tang, S., & Liu, L. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2570800
“…probiotics as having ‘significant antidepressant effects’ without adequate acknowledgment of substantial research limitations. recent meta-analyses [1,2] demonstrate that probiotics are effective in reducing depressive symptoms when administered in addition to antidepressants (sMD = 0.83, 95%ci…”
InfluentialThe Effect of Probiotics on Mental Health
Yılmaz, G. G. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-1414-4_12
Attenuating Neurotoxicity Through Fecal Microbiota Transplant: Mechanisms and Therapeutic Potential
Younis, N. K., Alfarttoosi, K. H., Sanghvi, G. V., Roopashree, R., Kashyap, A., Krithiga, T., Taher, W. M., Alwan, M., Jawad, M. J., & Al-Nuaimi, A. M. A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05415-1
“A systematic review by Nikolova et al. documented decreases in depressive symptoms when probiotics were paired with anti-depressants, but showed minimal advantages as standalone therapy [172].”
The Gut-Brain Axis: The effect of dysbiosis on mood disorders like anxiety and depression
Sangal, M. (2022) · Journal of High School Science · doi:10.64336/001c.56437 · Cited by 1
African Journal of Biomedical Research
Marchwiany, P., Stenka, W., Matzner, M., Niski, J., Moc, K., Kramek, J., Przeniosło, J., Grzelak, W., Kluczniok, J., & Sadowska, A. (2025) · African Journal of Biomedical Research · doi:10.53555//ajbr.v28i4s.8853
O PAPEL DA MICROBIOTA INTESTINAL E O USO DOS PROBIÓTICOS NO TRANSTORNO DEPRESSIVO MAIOR
Sancção, L. G., de Sá, L. S., & Ferriani, L. O. (2026) · Editora Científica Digital eBooks · doi:10.37885/260121007
Mosavat, S. H., Sahraian, A., Kalani, M., Namjoyan, F., & Ghasemi, Y. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07903-7 · Cited by 1
“Nikolova et al. in their meta-analysis highlighted the efficacy of probiotics as adjunctive therapy to antidepressants [43].”
Xu, X., Qin, B., Lei, T., Liu, X., Li, X., Li, Y., Zhang, J., Chen, F., Liu, C., Zhang, L., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08138-6
“As a result, whether gut microbiota profiles vary systematically across different levels of depressive severity during adolescence remains insufficiently characterized [34, 35].”
Emerging Therapeutic Interventions for Treatment‑Resistant Depression
Tamez, M. C. C., Scaini, G., & Quevedo, J. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_26
Oriquat, G., Abdulsahib, W. K., Mustafa, W. W., Patel, J. R., Jamuna, K. V., Tripathi, V., Sahoo, S., Bainsal, N., & Khalikova, N. (2026) · Current Psychology · doi:10.1007/s12144-026-09539-y
“Moreover, current evidence does not support probiotics as effective standalone therapies, as their benefits appear limited when used alone but more evident when administered alongside antidepressants (Nikolova et al. 2021 ).”
Wiśniewski, B., Pachnowska, D., Cholewiński, K., Badowska, N., Matuszek, I., Pluta, N., Nowak, K. A., Rutkowska-Nowosielska, A., Czekanow, O. N., Demkow, J., et al. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5674
Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy
Alaili, M. K. A. (2026) · Precision medication. · doi:10.1016/j.prmedi.2026.100098
Paliy, I. G., Ksenchyna, K., Kapitun, A. G., & Klymchuk, I. (2026) · Family medicine European practices · doi:10.30841/2786-720x.2.2026.365360
The in vitro study of the susceptibility of Bifidobacteria to antidepressantsPreprint
Mahayri, T. M., Killer, J., Jakob, L., Hakenova, K., Mrázek, J., Sechovcová, H., & Fliegerova, K. O. (2026) · Research Square · doi:10.21203/rs.3.rs-10521979/v1
Psychotropic Drugs: A Promising Non‐Antibiotic Agent to Combat Multi‐Drug‐Resistant Microorganisms
Singh, I. P., Singh, H., Sharma, D., Keshri, A., Gaurav, N., Dhakad, M. S., & Beg, M. M. A. (2026) · Drug Development Research · doi:10.1002/ddr.70380
“Probiotics are beneficial living micro-organisms capable of re‐establishing and modulating a healthy gut microbial system from dysbiotic conditions like depression‐ mediated dysbiosis (Nikolova et al. 2021).”
Zhang, Y., Li-shuang, Z., Zhang, K., & Liu, X.-L. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1900466
“Previous systematic reviews have suggested that probiotics may improve depressive symptoms; however, the clinical applicability of these findings remains uncertain because study populations were not always restricted to patients with formally established depressive disorders (16, 17).”
Zhang, Y., Pei, C., Zhang, D., & Liu, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1957715
“Other computational studies have explored microbial characteristics associated with symptom severity, treatment resistance, and antidepressant response, highlighting the potential contribution of AI-assisted microbiome analysis to individualized psychiatric care (37).”
Katchhi, M. S., Deeksha, N., Bhandari, B. S., Ahmad, A., Krishna, M., Fathima, F., Ming, L. C., & Siddappa, U. D. (2026) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.1177/0976500x261495642
Costa, A. H., da Silva, D. B., de Oliveira, M. K. C., Freitas, F. M. N. D. O., & dos Reis, D. S. (2026) · Derecho y cambio social. · doi:10.54899/dcs.v23i99.136
Metadata
- Authors
- Nikolova, V., Cleare, A., Young, A., & Stone, J.
- Affiliations
- King's College London (GB)
- Brighton and Sussex Medical School (GB)
- Corresponding author
- Nikolova, Viktoriya
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-02-08
- Volume
- 10
- Issue
- 4
- Pages
- 647
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7915600
- OpenAlex
- W3126375840
- Cited by
- 106
- References
- 58
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 14 · 2023: 26 · 2022: 13 · 2021: 12
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute for Health and Care Research (NF-SI-0616-10091, NIHR202380)
- Medical Research Council (2171139)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, major depressive disorder, adjunctive therapy, antidepressants, gut microbiota, depressive symptoms, brain-derived neurotrophic factor, C-reactive protein, antidepressant efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.